首页> 外文期刊>American Journal of Physiology >SIRT1-mediated deacetylation of NF-kB inhibits the MLCK/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm
【24h】

SIRT1-mediated deacetylation of NF-kB inhibits the MLCK/MLC2 pathway and the expression of ET-1, thus alleviating the development of coronary artery spasm

机译:SIRT1介导的NF-KB的脱乙酰化抑制MLCK / MLC2途径和ET-1的表达,从而减轻了冠状动脉痉挛的发育

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary artery spasm (CAS) is an intense vasoconstriction of coronary arteries that causes total or subtotal vessel occlusion. The cardioprotective effect of sirtuin-1 (SIRT1) has been extensively highlighted in coronary artery diseases. The aims within this study include the investigation of the molecular mechanism by which SIRT1 alleviates CAS. SIRT1 expression was first determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot analysis in an endothelin-1 (ET-1)-induced rat CAS model. Interaction among SIRT1, nuclear factor-kappaB (NF-kB), myosin light chain kinase/myosin light chain-2 (MLCK/MLC2), and ET-1 was analyzed using luciferase reporter assay, RT-qPCR, and Western blot analysis. After ectopic expression and depletion experiments in vascular smooth muscle cells (VSMCs), contraction and proliferation of VSMCs and expression of contraction-related proteins (a-SMA, calponin, and SM22a) were measured by collagen gel contraction, 5-ethynyl-2'-deoxyuri-dine (EdU) assay, RT-qPCR, and Western blot analysis. The obtained results showed that SIRT1 expression was reduced in rat CAS models. However, overexpression of SIRT1 inhibited the contraction and proliferation of VSMCs in vitro. Mechanistic investigation indicated that SIRT1 inhibited NF-kB expression through deacetylation. Moreover, NF-kB could activate the MLCK/MLC2 pathway and upregulate ET-1 expression by binding to their promoter regions, thus inducing VSMC contraction and proliferation in vitro. In vivo experimental results also revealed that SIRT1 alleviated CAS through regulation of the NF-kB/MLCK/MLC2/ET-1 signaling axis. Collectively, our data suggested that SIRT1 could mediate the deacetylation of NF-kB, disrupt the MLCK/MLC2 pathway, and inhibit the expression of ET-1 to relieve CAS, providing a theoretical basis for the prospect of CAS treatment and prevention.
机译:冠状动脉痉挛(CAS)是冠状动脉的一种强烈血管收缩,导致血管完全或次全闭塞。sirtuin-1(SIRT1)的心脏保护作用在冠状动脉疾病中被广泛强调。本研究的目的包括研究SIRT1缓解CAS的分子机制。在内皮素-1(ET-1)诱导的大鼠CAS模型中,首次通过逆转录定量聚合酶链反应(RT-qPCR)和Western blot分析确定SIRT1的表达。使用荧光素酶报告分析、RT-qPCR和Western blot分析分析SIRT1、核因子κB(NF-kB)、肌球蛋白轻链激酶/肌球蛋白轻链-2(MLCK/MLC2)和ET-1之间的相互作用。在血管平滑肌细胞(VSMC)中进行异位表达和耗竭实验后,通过胶原凝胶收缩、5-乙炔基-2'-脱氧尿嘧啶核苷(EdU)分析、RT-qPCR和Western blot分析,测量VSMC的收缩和增殖以及收缩相关蛋白(a-SMA、calponin和SM22a)的表达。结果表明,在大鼠CAS模型中,SIRT1表达降低。然而,SIRT1的过度表达在体外抑制了血管平滑肌细胞的收缩和增殖。机制研究表明SIRT1通过脱乙酰化抑制NF-kB的表达。此外,NF-kB可以激活MLCK/MLC2通路,并通过结合其启动子区域上调ET-1的表达,从而在体外诱导VSMC收缩和增殖。体内实验结果还显示,SIRT1通过调节NF-kB/MLCK/MLC2/ET-1信号轴减轻CAS。总之,我们的数据表明SIRT1可以介导NF-kB的脱乙酰化,破坏MLCK/MLC2通路,抑制ET-1的表达以缓解CAS,为CAS的治疗和预防前景提供了理论基础。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号